Knott David M Jr Ligand Pharmaceuticals Inc Transaction History

Knott David M Jr

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$68.53 - $87.91 $2.06 Million - $2.64 Million	-30,000 Reduced 26.09%	85,000 $7.16 Million
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $3.8 Million - $6.06 Million	40,000 Added 53.33%	115,000 $12.9 Million
Q4 2021 Feb 11, 2022	BUY	$127.69 - $165.85 $9.58 Million - $12.4 Million	75,000 New	75,000 $11.6 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.